yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q37182194-6C40C514-F1EC-414D-97E4-C875632D4D12
Q37182194-6C40C514-F1EC-414D-97E4-C875632D4D12
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37182194-6C40C514-F1EC-414D-97E4-C875632D4D12
Acute tumour response to the MEK1/2 inhibitor selumetinib (AZD6244, ARRY-142886) evaluated by non-invasive diffusion-weighted MRI.
P1476
Q37182194-6C40C514-F1EC-414D-97E4-C875632D4D12
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37182194-6C40C514-F1EC-414D-97E4-C875632D4D12
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f6b7d0c93e2940dd33034c09ee10b9d50eb09d14
P1476
Acute tumour response to the M
......
nvasive diffusion-weighted MRI
@en